Avacta Group Plc (LON:AVCT - Get Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 38.12 ($0.51) and traded as low as GBX 33.50 ($0.45). Avacta Group shares last traded at GBX 33.75 ($0.46), with a volume of 3,483,862 shares traded.
Avacta Group Trading Up 14.9%
The firm has a 50-day moving average price of GBX 32.65 and a 200-day moving average price of GBX 37.83. The company has a debt-to-equity ratio of 52.53, a quick ratio of 4.96 and a current ratio of 1.29. The stock has a market cap of £176.75 million, a PE ratio of -5.99 and a beta of 1.12.
Avacta Group (LON:AVCT - Get Free Report) last issued its earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) (($0.12)) earnings per share (EPS) for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. As a group, equities analysts anticipate that Avacta Group Plc will post -9.9011833 EPS for the current fiscal year.
Avacta Group Company Profile
(
Get Free Report)
Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).
See Also
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
